药物科学的后基因组学和大数据时代是快速而激动人心的变化之一。在人类基因组计划，下一代测序（NGS）技术和大数据计算能力的推动下，从药物发现到交付再到反应的药物科学家研究途径已广泛开放。在这个新的分子和细胞药物时代的最前沿，是罗格斯大学的欧内斯特·马里奥药学院的药学专业研究生课程，在2010年国家研究委员会（NRC）评级中位居该领域的顶级课程之列。
The post-genomic and Big Data era in pharmaceutical science is one of rapid and exciting change. Research avenues for pharmaceutical scientists?from drug discovery to delivery to response?are wide open, driven by the completion of the Human Genome Project, Next Generation Sequencing (NGS) technology and Big-Data computational capability. At the forefront of this new era of molecular and cellular pharmaceutics is the graduate program in pharmaceutical science at Rutgers? Ernest Mario School of Pharmacy, ranked among the top programs in this field in the 2010 National Research Council (NRC) ratings.